BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30520817)

  • 1. The HTN3-MSANTD3 Fusion Gene Defines a Subset of Acinic Cell Carcinoma of the Salivary Gland.
    Andreasen S; Varma S; Barasch N; Thompson LDR; Miettinen M; Rooper L; Stelow EB; Agander TK; Seethala RR; Chiosea SI; Homøe P; Wessel I; Larsen SR; Erentaite D; Bishop JA; Ulhøi BP; Kiss K; Melchior LC; Pollack JR; West RB
    Am J Surg Pathol; 2019 Apr; 43(4):489-496. PubMed ID: 30520817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PON3::LCN1 and HTN3::MSANTD3 Gene Fusions With NR4A3/NR4A2 Expression in Salivary Acinic Cell Carcinoma.
    Zhu L; Sun L; Zhang Y; Liu X; Li X; Zhou Z; Cui Y; Zhou CX; Li TJ
    Am J Surg Pathol; 2024 Jun; 48(6):681-690. PubMed ID: 38682454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent rearrangements of the Myb/SANT-like DNA-binding domain containing 3 gene (MSANTD3) in salivary gland acinic cell carcinoma.
    Barasch N; Gong X; Kwei KA; Varma S; Biscocho J; Qu K; Xiao N; Lipsick JS; Pelham RJ; West RB; Pollack JR
    PLoS One; 2017; 12(2):e0171265. PubMed ID: 28212443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear NR4A3 Immunostaining Is a Specific and Sensitive Novel Marker for Acinic Cell Carcinoma of the Salivary Glands.
    Haller F; Skálová A; Ihrler S; Märkl B; Bieg M; Moskalev EA; Erber R; Blank S; Winkelmann C; Hebele S; Baněčková M; Wiemann S; Müller S; Zenk J; Eils R; Iro H; Hartmann A; Agaimy A
    Am J Surg Pathol; 2019 Sep; 43(9):1264-1272. PubMed ID: 31094928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NR4A3 Expression Is Consistently Absent in Acinic Cell Carcinomas of the Breast: A Potential Nosologic Shift.
    Richardson ET; Selenica P; Pareja F; Cin PD; Hanlon E; Weigelt B; Reis-Filho JS; Hornick JL; Jo VY; Schnitt SJ
    Mod Pathol; 2023 Jun; 36(6):100144. PubMed ID: 36828363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammary analog secretory carcinoma of salivary gland origin with the ETV6 gene rearrangement by FISH: expanded morphologic and immunohistochemical spectrum of a recently described entity.
    Connor A; Perez-Ordoñez B; Shago M; Skálová A; Weinreb I
    Am J Surg Pathol; 2012 Jan; 36(1):27-34. PubMed ID: 21989350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of mammary analogue secretory carcinoma of the salivary gland: discrimination from its mimics by the presence of the ETV6-NTRK3 translocation and novel surrogate markers.
    Urano M; Nagao T; Miyabe S; Ishibashi K; Higuchi K; Kuroda M
    Hum Pathol; 2015 Jan; 46(1):94-103. PubMed ID: 25456394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NCOA4-RET and TRIM27-RET Are Characteristic Gene Fusions in Salivary Intraductal Carcinoma, Including Invasive and Metastatic Tumors: Is "Intraductal" Correct?
    Skálová A; Ptáková N; Santana T; Agaimy A; Ihrler S; Uro-Coste E; Thompson LDR; Bishop JA; Baněčkova M; Rupp NJ; Morbini P; de Sanctis S; Schiavo-Lena M; Vanecek T; Michal M; Leivo I
    Am J Surg Pathol; 2019 Oct; 43(10):1303-1313. PubMed ID: 31162284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemistry with a pan-TRK antibody distinguishes secretory carcinoma of the salivary gland from acinic cell carcinoma.
    Hung YP; Jo VY; Hornick JL
    Histopathology; 2019 Jul; 75(1):54-62. PubMed ID: 30801752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NR4A3 fluorescence in situ hybridization analysis in cytologic and surgical specimens of acinic cell carcinoma.
    Shi Q; Zhang B; Bsirini C; Li L; Giampoli EJ; Magliocca KR; Reid M; Zhou Z
    Hum Pathol; 2022 Sep; 127():86-91. PubMed ID: 35700750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity.
    Skálová A; Vanecek T; Sima R; Laco J; Weinreb I; Perez-Ordonez B; Starek I; Geierova M; Simpson RH; Passador-Santos F; Ryska A; Leivo I; Kinkor Z; Michal M
    Am J Surg Pathol; 2010 May; 34(5):599-608. PubMed ID: 20410810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbonic anhydrase VI: a novel marker for salivary serous acinar differentiation and its application to discriminate acinic cell carcinoma from mammary analogue secretory carcinoma of the salivary gland.
    Hsieh MS; Jeng YM; Jhuang YL; Chou YH; Lin CY
    Histopathology; 2016 Apr; 68(5):641-7. PubMed ID: 26212680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A minority of cases of acinic cell carcinoma of the salivary glands are driven by an NR4A2 rearrangement: the diagnostic utility of the assessment of NR4A2 and NR4A3 alterations in salivary gland tumors.
    Klubíčková N; Grossmann P; Šteiner P; Baněčková M; Mosaieby E; Koshyk O; Michal M; Leivo I; Skálová A
    Virchows Arch; 2023 Feb; 482(2):339-345. PubMed ID: 36469101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re-evaluating historic cohort of salivary acinic cell carcinoma with new diagnostic tools.
    Lei Y; Chiosea SI
    Head Neck Pathol; 2012 Jun; 6(2):166-70. PubMed ID: 22127547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The profile of acinic cell carcinoma after recognition of mammary analog secretory carcinoma.
    Chiosea SI; Griffith C; Assaad A; Seethala RR
    Am J Surg Pathol; 2012 Mar; 36(3):343-50. PubMed ID: 22301503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancer hijacking activates oncogenic transcription factor NR4A3 in acinic cell carcinomas of the salivary glands.
    Haller F; Bieg M; Will R; Körner C; Weichenhan D; Bott A; Ishaque N; Lutsik P; Moskalev EA; Mueller SK; Bähr M; Woerner A; Kaiser B; Scherl C; Haderlein M; Kleinheinz K; Fietkau R; Iro H; Eils R; Hartmann A; Plass C; Wiemann S; Agaimy A
    Nat Commun; 2019 Jan; 10(1):368. PubMed ID: 30664630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Profiling of Salivary Gland Intraductal Carcinoma Revealed a Subset of Tumors Harboring NCOA4-RET and Novel TRIM27-RET Fusions: A Report of 17 cases.
    Skálová A; Vanecek T; Uro-Coste E; Bishop JA; Weinreb I; Thompson LDR; de Sanctis S; Schiavo-Lena M; Laco J; Badoual C; Santana Conceiçao T; Ptáková N; Baněčkova M; Miesbauerová M; Michal M
    Am J Surg Pathol; 2018 Nov; 42(11):1445-1455. PubMed ID: 30045065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Papillary-cystic pattern is characteristic in mammary analogue secretory carcinomas but is rarely observed in acinic cell carcinomas of the salivary gland.
    Hsieh MS; Chou YH; Yeh SJ; Chang YL
    Virchows Arch; 2015 Aug; 467(2):145-53. PubMed ID: 25976476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrastructural Characterization of Mammary Analogue Secretory Carcinoma of the Salivary Glands: A Distinct Entity from Acinic Cell Carcinoma?
    Guilmette J; Nielsen GP; Faquin WC; Selig M; Nosé V; Chi AWS; Sadow PM
    Head Neck Pathol; 2017 Dec; 11(4):419-426. PubMed ID: 28194567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanding the Molecular Spectrum of Secretory Carcinoma of Salivary Glands With a Novel VIM-RET Fusion.
    Skálová A; Banečkova M; Thompson LDR; Ptáková N; Stevens TM; Brcic L; Hyrcza M; Michal M; Simpson RHW; Santana T; Michal M; Vaněček T; Leivo I
    Am J Surg Pathol; 2020 Oct; 44(10):1295-1307. PubMed ID: 32675658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.